Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,350
-240 (-1.91%)
Feb 19, 2025, 9:00 AM KST
46.50%
Market Cap 261.76B
Revenue (ttm) 212.42B
Net Income (ttm) -1.17B
Shares Out 21.23M
EPS (ttm) -71.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 190,893
Average Volume 249,540
Open 12,510
Previous Close 12,590
Day's Range 12,300 - 12,560
52-Week Range 7,800 - 19,500
Beta 0.40
RSI 40.17
Earnings Date Mar 14, 2025

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se... [Read more]

Sector Healthcare
Founded 1947
Employees 585
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.